280 related articles for article (PubMed ID: 24930083)
1. [Alternatives to conventional diuretic therapy in heart failure].
Morales-Rull JL; Trullàs JC; Formiga F
Med Clin (Barc); 2014 Mar; 142 Suppl 1():42-8. PubMed ID: 24930083
[TBL] [Abstract][Full Text] [Related]
2. [Diuretic therapy in acute heart failure].
Trullàs JC; Morales-Rull JL; Formiga F
Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
[TBL] [Abstract][Full Text] [Related]
3. Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
Takada T; Masaki T; Hoshiyama A; Toki T; Kamata Y; Shichiri M
Nephrology (Carlton); 2018 Sep; 23(9):883-886. PubMed ID: 29665203
[TBL] [Abstract][Full Text] [Related]
4. Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.
Hanatani A; Shibata A; Kitada R; Iwata S; Matsumura Y; Doi A; Sugioka K; Takagi M; Yoshiyama M
Heart Vessels; 2017 Mar; 32(3):287-294. PubMed ID: 27385022
[TBL] [Abstract][Full Text] [Related]
5. Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR.
Ikeda Y; Inomata T; Kida K; Shibagaki Y; Sato N; Izumi T; Ako J;
Heart Vessels; 2019 Mar; 34(3):442-451. PubMed ID: 30259172
[TBL] [Abstract][Full Text] [Related]
6. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
7. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
[TBL] [Abstract][Full Text] [Related]
8. Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
Tominaga N; Kida K; Inomata T; Sato N; Izumi T; Akashi YJ; Shibagaki Y
Am J Nephrol; 2017; 46(5):417-426. PubMed ID: 29130954
[TBL] [Abstract][Full Text] [Related]
9. Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis.
Ando T; Okuhara Y; Orihara Y; Nishimura K; Yamamoto K; Masuyama T; Hirotani S
Heart Vessels; 2018 Sep; 33(9):1029-1036. PubMed ID: 29556693
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
[TBL] [Abstract][Full Text] [Related]
11. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Matsue Y; Suzuki M; Nagahori W; Yoshida K; Onishi Y; Satoh Y; Ono Y; Nishioka T; Noda M; Sugi K; Torii S; Tejima T; Sakurada H; Yamaguchi S; Okishige K; Fujii H; Takahashi A
Cardiovasc Drugs Ther; 2014 Feb; 28(1):73-7. PubMed ID: 24048511
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
14. Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.
Nakamura M; Sunagawa O; Kinugawa K
Int Heart J; 2018; 59(1):87-93. PubMed ID: 29375117
[TBL] [Abstract][Full Text] [Related]
15. Tolvaptan in a pediatric patient with diuretic-resistant heart and kidney failure.
Hirano D; Kakegawa D; Yamada A; Ito A; Miwa S; Ida H
Pediatr Int; 2015; 57(1):183-5. PubMed ID: 25711263
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Kissling KT; Pickworth KK
Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
[TBL] [Abstract][Full Text] [Related]
17. Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study.
Tominaga N; Kida K; Matsumoto N; Akashi YJ; Miyake F; Kimura K; Shibagaki Y
Clin Nephrol; 2015 Jul; 84(1):29-38. PubMed ID: 25997504
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of extracorporeal ultrafiltration in patients with diuretic-resistant heart failure.
Nakazawa N; Nakabayashi K; Oka T
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27702934
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
20. Diuretics and ultrafiltration in acute decompensated heart failure.
Felker GM; Mentz RJ
J Am Coll Cardiol; 2012 Jun; 59(24):2145-53. PubMed ID: 22676934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
